{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:59:28Z","timestamp":1794412768208,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To investigate the value of vascular morphology on high frame rate contrast-enhanced ultrasound (H-CEUS) and CEUS Li-RADS in predicting microvascular invasion (MVI), Ki-67 expression and recurrence of hepatocellular carcinoma (HCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study enrolled 78 patients with single HCC diagnosed by postoperative pathology between January 1, 2021, and June 30, 2022. All patients underwent ultrasound and H-CEUS examination before operation. H-CEUS image features and CEUS Li-RADS were compared in different MVI status and Ki-67 level. Multiple logistic regression analysis was performed to select independent variables for MVI. Differences in recurrence among different H-CEUS image features, MVI status and Ki-67 level were further analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Tumor shape, vascular morphology, LR-M category, necrosis and AFP level were different between the MVI-positive group and MVI-negative group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Vascular morphology and LR-M category were independent risk factors related to MVI (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Vascular morphology was also different between the high Ki-67 expression group and low Ki-67 expression group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Vascular morphology, MVI status and Ki-67 expression were different between the recurrence group and no recurrence group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The vascular morphology of HCC on H-CEUS can indicate the risk of MVI status, Ki-67 expression and recurrence, which provides a feasible imaging technique for predicting the prognosis before operation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevance statement<\/jats:title>\n                <jats:p>H-CEUS shows the different vascular morphology of HCC in arterial phase and indicates the risk of MVI, Ki-67 expression and recurrence, which provides a feasible imaging technique for clinician to judge the risk of MVI pre-operation and adopt appropriate treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>H-CEUS can clearly show different vascular morphology of HCC in arterial phase.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Vascular morphology on H-CEUS is associated with MVI status, Ki-67 expression and HCC recurrence.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Preoperative MVI and Ki-67 expression prediction could help surgeons choose a more appropriate treatment plan.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-024-01821-6","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:59:27Z","timestamp":1731675567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Value of high frame rate contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiang","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Andr\u00e9","family":"Clevert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5944-8198","authenticated-orcid":false,"given":"Yukun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"1821_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450\u20131462","journal-title":"N Engl J Med"},{"key":"1821_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1821_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"1821_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70:151\u2013171","journal-title":"J Hepatol"},{"key":"1821_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","volume":"19","author":"KA McGlynn","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT (2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19:223\u2013238","journal-title":"Clin Liver Dis"},{"key":"1821_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.transproceed.2017.09.063","volume":"50","author":"P Cascales-Campos","year":"2018","unstructured":"Cascales-Campos P, Martinez-Insfran LA, Ramirez P et al (2018) Liver transplantation in patients with hepatocellular carcinoma outside the Milan criteria after downstaging: is it worth it? Transplant Proc 50:591\u2013594","journal-title":"Transplant Proc"},{"key":"1821_CR7","first-page":"6","volume":"59","author":"YX Xia","year":"2021","unstructured":"Xia YX, Zhang F, Li XC et al (2021) Surgical treatment of primary liver cancer: a report of 10 966 cases. Zhonghua Wai Ke Za Zhi 59:6\u201317","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"1821_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CH-201085","volume":"77","author":"Y Dong","year":"2021","unstructured":"Dong Y, Qiu Y, Yang D et al (2021) Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Clin Hemorheol Microcirc 77:461\u2013469","journal-title":"Clin Hemorheol Microcirc"},{"key":"1821_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1148\/radiol.13130387","volume":"269","author":"Y Takuma","year":"2013","unstructured":"Takuma Y, Takabatake H, Morimoto Y et al (2013) Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 269:927\u2013937","journal-title":"Radiology"},{"key":"1821_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1148\/radiol.2471070818","volume":"247","author":"K Yamakado","year":"2008","unstructured":"Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260\u2013266","journal-title":"Radiology"},{"key":"1821_CR11","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1245\/s10434-019-07227-9","volume":"26","author":"DJ Erstad","year":"2019","unstructured":"Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474\u20131493","journal-title":"Ann Surg Oncol"},{"key":"1821_CR12","doi-asserted-by":"publisher","first-page":"181006","DOI":"10.1098\/rsos.181006","volume":"5","author":"O Menyh\u00e1rt","year":"2018","unstructured":"Menyh\u00e1rt O, Nagy \u00c1, Gy\u0151rffy B (2018) Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci 5:181006","journal-title":"R Soc Open Sci"},{"key":"1821_CR13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/lt.24811","volume":"23","author":"CM Court","year":"2017","unstructured":"Court CM, Harlander-Locke MP, Markovic D et al (2017) Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection. Liver Transpl 23:1123\u20131132","journal-title":"Liver Transpl"},{"key":"1821_CR14","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1245\/s10434-019-07365-0","volume":"26","author":"H Nitta","year":"2019","unstructured":"Nitta H, Allard MA, Sebagh M et al (2019) Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma. Ann Surg Oncol 26:2568\u20132576","journal-title":"Ann Surg Oncol"},{"key":"1821_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ultrasmedbio.2021.11.005","volume":"48","author":"X Li","year":"2022","unstructured":"Li X, Han X, Li L et al (2022) Dynamic contrast-enhanced ultrasonography with sonazoid for diagnosis of microvascular invasion in hepatocellular carcinoma. Ultrasound Med Biol 48:575\u2013581","journal-title":"Ultrasound Med Biol"},{"key":"1821_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ultrasmedbio.2017.04.003","volume":"43","author":"W Zhu","year":"2017","unstructured":"Zhu W, Qing X, Yan F, Luo Y, Li Y, Zhou X (2017) Can the contrast-enhanced ultrasound washout rate be used to predict microvascular invasion in hepatocellular carcinoma? Ultrasound Med Biol 43:1571\u20131580","journal-title":"Ultrasound Med Biol"},{"key":"1821_CR17","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1007\/s00330-018-5797-0","volume":"29","author":"HT Hu","year":"2019","unstructured":"Hu HT, Wang Z, Huang XW et al (2019) Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol 29:2890\u20132901","journal-title":"Eur Radiol"},{"key":"1821_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ar.20668","volume":"291","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Poon RT (2008) Vascular changes in hepatocellular carcinoma. Anat Rec 291:721\u2013734","journal-title":"Anat Rec"},{"key":"1821_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1148\/radiol.2443061520","volume":"244","author":"HJ Jang","year":"2007","unstructured":"Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 244:898\u2013906","journal-title":"Radiology"},{"key":"1821_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14218\/JCTH.2020.00172","volume":"10","author":"X Fei","year":"2022","unstructured":"Fei X, Han P, Jiang B et al (2022) High frame rate contrast-enhanced ultrasound helps differentiate malignant and benign focal liver lesions. J Clin Transl Hepatol 10:26\u201333","journal-title":"J Clin Transl Hepatol"},{"key":"1821_CR21","first-page":"10235","volume":"8","author":"Y Luo","year":"2015","unstructured":"Luo Y, Ren F, Liu Y et al (2015) Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med 8:10235\u201310247","journal-title":"Int J Clin Exp Med"},{"key":"1821_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2147\/CMAR.S162595","volume":"10","author":"C Yang","year":"2018","unstructured":"Yang C, Su H, Liao X et al (2018) Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res 10:679\u2013696","journal-title":"Cancer Manag Res"},{"key":"1821_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13244-022-01320-6","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang Z, Zhou P, Li S, Li K (2022) Prediction of the Ki-67 marker index in hepatocellular carcinoma based on dynamic contrast-enhanced ultrasonography with sonazoid. Insights Imaging 13:199","journal-title":"Insights Imaging"},{"key":"1821_CR24","first-page":"5084","volume":"16","author":"MW Juan","year":"2018","unstructured":"Juan MW, Yu J, Peng GX, Jun LJ, Feng SP, Fang LP (2018) Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer. Oncol Lett 16:5084\u20135090","journal-title":"Oncol Lett"},{"key":"1821_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00535-013-0830-1","volume":"49","author":"H Tanaka","year":"2014","unstructured":"Tanaka H, Iijima H, Higashiura A et al (2014) New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol 49:755\u2013763","journal-title":"J Gastroenterol"},{"key":"1821_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-0042-124369","volume":"38","author":"Y Kono","year":"2017","unstructured":"Kono Y, Lyshchik A, Cosgrove D et al (2017) Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS\u00ae): the official version by the American College of Radiology (ACR). Ultraschall Med 38:85\u201386","journal-title":"Ultraschall Med"},{"key":"1821_CR27","doi-asserted-by":"publisher","first-page":"E438","DOI":"10.1111\/ans.15403","volume":"89","author":"W Lu","year":"2019","unstructured":"Lu W, Tang H, Yang Z, Jiang K, Chen Y, Lu S (2019) Clinical predictors of small solitary hepatitis B virus-related hepatocellular carcinoma microinvasion. ANZ J Surg 89:E438\u2013E442","journal-title":"ANZ J Surg"},{"key":"1821_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","volume":"273","author":"S Lee","year":"2021","unstructured":"Lee S, Kang TW, Song KD et al (2021) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg 273:564\u2013571","journal-title":"Ann Surg"},{"key":"1821_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1148\/radiol.2019181818","volume":"292","author":"Z Peng","year":"2019","unstructured":"Peng Z, Chen S, Xiao H et al (2019) Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma. Radiology 292:237\u2013247","journal-title":"Radiology"},{"key":"1821_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/CH-211190","volume":"80","author":"P Wang","year":"2022","unstructured":"Wang P, Nie F, Dong T, Wang G, Wang L, Fan X (2022) Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma. Clin Hemorheol Microcirc 80:97\u2013106","journal-title":"Clin Hemorheol Microcirc"},{"key":"1821_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10396-016-0750-9","volume":"44","author":"K Sugimori","year":"2017","unstructured":"Sugimori K, Numata K, Okada M et al (2017) Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US. J Med Ultrason 44:89\u2013100","journal-title":"J Med Ultrason"},{"key":"1821_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/a-1168-6321","volume":"43","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhang C, Du L et al (2022) Contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing hepatocellular carcinoma: diagnostic performance and interobserver agreement. Ultraschall Med 43:64\u201371","journal-title":"Ultraschall Med"},{"key":"1821_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.699290","volume":"11","author":"H Zhou","year":"2021","unstructured":"Zhou H, Sun J, Jiang T et al (2021) A nomogram based on combining clinical features and contrast enhanced ultrasound Li-RADS improves prediction of microvascular invasion in hepatocellular carcinoma. Front Oncol 11:699290","journal-title":"Front Oncol"},{"key":"1821_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1148\/radiol.2522081414","volume":"252","author":"A Kitao","year":"2009","unstructured":"Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation. Radiology 252:605\u2013614","journal-title":"Radiology"},{"key":"1821_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5152\/dir.2015.15125","volume":"22","author":"E \u00dcnal","year":"2016","unstructured":"\u00dcnal E, \u0130dilman \u0130S, Akata D, \u00d6zmen MN, Kar\u00e7aalt\u0131ncaba M (2016) Microvascular invasion in hepatocellular carcinoma. Diagn Interv Radiol 22:125\u2013132","journal-title":"Diagn Interv Radiol"},{"key":"1821_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/hepr.12196","volume":"44","author":"F Hirokawa","year":"2014","unstructured":"Hirokawa F, Hayashi M, Miyamoto Y et al (2014) Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 44:846\u2013853","journal-title":"Hepatol Res"},{"key":"1821_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.aohep.2020.07.002","volume":"19","author":"YZ He","year":"2020","unstructured":"He YZ, He K, Huang RQ et al (2020) Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis. Ann Hepatol 19:654\u2013661","journal-title":"Ann Hepatol"},{"key":"1821_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002360","volume":"266","author":"J Zheng","year":"2017","unstructured":"Zheng J, Chou JF, G\u00f6nen M et al (2017) Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: validation of a clinical risk score in an international cohort. Ann Surg 266:693\u2013701","journal-title":"Ann Surg"},{"key":"1821_CR39","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/hep4.2063","volume":"6","author":"C Gozzo","year":"2022","unstructured":"Gozzo C, Hermida M, Herrero A et al (2022) Non-transplantable recurrence after percutaneous thermal ablation of \u2264 3-cm HCC: predictors and implications for treatment allocation. Hepatol Commun 6:2975\u20132987","journal-title":"Hepatol Commun"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01821-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01821-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01821-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T13:03:08Z","timestamp":1731675788000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01821-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01821-6","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Chinese PLA General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}